CV Stimulants Flashcards

1
Q

Alpha receptors in blood vessels affect

A

contraction on the vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Affects of epinephrine

A

locally increase BP through alpha receptors; increase HR and CO through Beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Affects of norepinephrine

A

increased BP through alpha receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Affects of dopamine

A

at high doses increase BP (alpha) and increase HR and CO (beta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Affects of isoproterenol

A

increase HR and CO (beta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Affects of Phenylephrine

A

increase BP (alpha)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Affects of ephedrine

A

at high doses increase BP (alpha) and increase HR and CO (beta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Activation of Alpha 1

A

formation of IP3 and DAG, increased intracellular calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Activation of Alpha 2:

A

inhibition of adenylyl cyclase, decreased cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Activation of Beta 1:

A

stimulation of adenylyl cyclase, increased cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Activation of Beta 2:

A

stimulation of adenylyl cyclase and increased cAMP

Activates cardiac Gi under some conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Activation of Beta 3:

A

stimulation of adenylyl cyclase and increased cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Activation of D1 and D5

A

stimulation of adenylyl cyclase and increased cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Activation of D2

A

decreased adenylyl cyclase; increase K+ conductance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Direct acting drugs MOA

A

stimulate postsynaptic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indirect acting drugs MOA:

A

increase availability of NE or E by releasing or displacing NE from sympathetic nerves, blocking transport of NE into sympathetic neurons, block metabolizing enzymes

17
Q

Mixed-acting drugs

A

direct activation of postsynaptic receptors and indirect release of NE

18
Q

Reserpine’s effect on effectiveness of direct, indirected, and mixed-acting drugs

A

Direct: response are not reduced

Indirect: responses are abolished

Mixed: responses are blunted, but not abolished

19
Q

Differences in CV effects by E and NE

A

E: increases HR, CO, unpredictable effect on diastolic arterial pressure with large increase in systolic, decreased peripheral resistance

NE decreases HR and has no effect or decreases CO, increases Diastolic arterial pressure and large increase in systolic, increased peripheral resistance

20
Q

Epinephrine effect on the heart

A

increased HR, shortened systole, increased CO, increased Oxygen consumption

Can cause premature ventricular contractions, leading to extrasystoles, tachycardia, or fibrillation

21
Q

Epinephrine vascular effects

A

decreased cutaneous BF, increased B2 mediated skeletal BF, increased renal resistance with decreased BF, increased pulmonary pressures, and increased coronary BF

22
Q

Epinephrine absorption

A

IV, Inhaled, IM, SC (slow due to vasoconstriction)

Cannot give orally due to high metabolic rate

23
Q

Epinephrine toxicity

A

Cerebral hemorrhage especially with non-specific beta blockers, ventricular arrhythmias, and angina

24
Q

Uses of epinephrine

A

emergency relief of hypersensitivity reactions, vasoconstrictor with local anesthetics, topical hemostatic agent, restoring cardiac rhythm in patients with cardiac arrest

25
Q

Toxicity of norepinephrine

A

cerebral hemorrhage, ventricular arrhythmias, angina, extreme increases in BP, necrosis at sites of IV infusion

26
Q

Dopamine

A

Concentration dependent receptor specificity from low to high dose (D1 -> B1 -> A)

Used acutely in CHD or RF

Given IV infusion; has short duration of action

Must monitor urine output as secondary marker of drug effect - may have bad effects on kidneys, where it is metabolized

27
Q

Dobutamine

A

Racemic mixture of a beta agonsit and alpha1 agonist and antagonist

Increases CO and SV without effect on HR through increased myocardial contractility with decreased LV filling pressure; increased urinary output secondary to increased CO

Very short half life (2min), IV

For short term treatment of cardiac decompensation post surgery, CHF, or acute MI

28
Q

Isoproterenol

A

Acts on beta receptors; increases CO, decreases diastolic BP

Given parenteral or by aerosol

SE: palpitations, tachy, headache, flushing

Uses: Emergency to stimulate HR in pts with brady or heart block - especially patients with torsades or about to receive implanted pacemaker

29
Q

Phenylephrine

A

Direct acting alpha adrenergic agonsit; causses systemic vasoconstriction, thus increased SBP&DBP

Can cause reflex decreased HR and CO

SC, IM, IV

use of control of hypotension (also associated with regional/spinal anesthesia

SE: angine, anxiety, hallucinations, HTN, excitability, dizziness, insomnia, pallor, restlessness - all more likely with parenteral administration

30
Q

Ephedrine

A

Mixed acting sympathomimetic agonist at both alpha and beta receptors and enhances release of NE from sympathetic neurons

Orally active, eliminated unchanged in urine

Uses: hyptonesion and hypotension of analgesia

increased HR and CO, variable increased in peripheral resistance and BP

SE: angina, ventricular dysfunction including arrhythmias and palpitations, fatal arrhythmias including V tach